Boehringer Ingelheim Animal Health Has been Supporting Independent Research on PCV2 for One Decade
GLOBAL - For the tenth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past ten years, 29 research projects have been awarded with € 25,000.
6 March 2017
2 minute read
By: More than 30 European scientists joined the award ceremony, which took place in Lyon, France. The 2016 European PCV2 research awards were granted to the laureates by the head of the review board, Professor Maurice Pensaert, former head of the Laboratory of Virology of Ghent University in Belgium. The independent review board selected the following projects to be funded:
- Tanja Opriessnig (The Roslin Institute, University of Edinburgh; UK): Characterizing and contrasting the humoral immune responses against PCV2a and PCV2d
- Xaver Sidler, Titus Sydler and Enrico Brugnera (University of Zurich, Switzerland): Is PCV2 very closely associated with the pig’s germline cells?
- Gonzalo López Lorenzo (University of Santiago de Compostela, Spain): Application of environmental detection of PCV2 through the use of qPCR in the epidemiological study of infection.
Boehringer Ingelheim is committed to continuously support independent applied research in the field of PCV2 immunity, pathogenesis, epidemiology and interaction with other (potential) pathogens. For questions or proposals on PCV2 research projects please contact Dr. Bernd Große Liesner, Global Technical Manager Swine Biologicals with Boehringer Ingelheim Animal Health ([email protected]).
